POC Infectious Diseases market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global POC Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the POC Infectious Diseases market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV
Segment by Application
Hospital& Clinics
Clinical Diagnostic Laboratories
Homecare Settings
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Cepheid
Diamedix
Diasorin
Eiken Chemical
Enzo Biochem